ACR Urges Caution When Using BI-RADS for Pediatric Breast Masses
ACR guidance says BI-RADS was designed for adult breast imaging and should not guide care for most pediatric breast masses.
Read moreThis article was updated Nov. 12 to reflect that this shortage is not related to the Brevera 9-gauge stereotactic breast biopsy needle recall.
This article was updated Nov. 12 to reflect that this shortage is not related to the Brevera 9-gauge stereotactic breast biopsy needle recall.
The American College of Radiology® (ACR®) offers the following information for breast imaging physicians and their practices to mitigate patient care disruptions due to a shortage of MRI breast biopsy needles.
Hologic informed users that it has voluntarily stopped shipment of ATEC® breast biopsy needles to clients following the internal identification of a manufacturing defect that requires further investigation.
Hologic does not anticipate being able to resume supply of ATEC needles before early 2027. This represents their earliest current estimate and may change as their investigation and testing progress to identify the manufacturing defect.
This supply interruption is not related to the Brevera 9-gauge stereotactic breast biopsy needle recall announced in late 2025. Hologic states that ATEC needles currently in inventory may continue to be used in accordance with their approved labeling and instructions for use.
Radiology leaders should work closely with hospital systems, referring providers and patients to coordinate safe and effective care. Due to local factors, it may not be possible for individual practices to adopt all these recommendations.
Imaging providers should consult their legal counsel to ensure that steps outlined below meet any local, state or federal requirements and regulations. These mitigation strategies are suggestions and may not be applicable in all practices and situations.
ACR Urges Caution When Using BI-RADS for Pediatric Breast Masses
ACR guidance says BI-RADS was designed for adult breast imaging and should not guide care for most pediatric breast masses.
Read moreDoctor Groups Oppose OON Payments Bill
Radiology, emergency medicine and anesthesiology leaders urge Congress to preserve independent arbitration and reject insurer-controlled out-of-network payment policies.
Read moreAnalysis Shows Insurers Undermine No Surprises Act IDR Process
Insurers use unrealistically low initial payments, flawed Qualifying Payment Amounts, and impractical contracting terms to push physicians to the IDR process.
Read more